Co-morbidity of autoimmune diseases: number of observed and expected people with zero, one and more than one autoimmune disease.

<p>Co-morbidity of autoimmune diseases: number of observed and expected people with zero, one and more than one autoimmune disease.</p

Absolute frequencies of people with zero, one, or more than one autoimmune diseases.

<p>Absolute frequencies of people with zero, one, or more than one autoimmune diseases.</p

Prevalence of each autoimmune disease per 100000 people.

<p>Prevalence of each autoimmune disease per 100000 people.</p

Prevalence of autoimmune diseases according to gender.

<p>Prevalence of autoimmune diseases according to gender.</p

Multivariable GLMMs results.

<p>Multivariable GLMMs results.</p

Results of principal component analysis (PCA).

<p>Results of principal component analysis (PCA).</p

Scree plots of the principal component analysis (with and without copper).

<p>Scree plots of the principal component analysis (with and without copper).</p

The 25 municipalities forming the study area, the sampling sites and the ore bodies.

<p>The 25 municipalities forming the study area, the sampling sites and the ore bodies.</p

Inheritance of HLA-DRB1*16:01-DQB1*05:02 in the absence of the negatively associated HLA-DRB1*15:02-DQB1*06:01.

<p>Legend: HLA-DRB1*16:01-DQB1*05:02 (16); X includes the positively associated DRB1*03:01-DQB1*02:01, DRB1*13:03-DQB1*03:01, DRB1*15:01-DQB1*06:02, DRB1*04:05-DQB1*03:01 and “neutral” haplotypes; p value (P). NA means that offspring genotypes are not possible with parental genotypes.</p

Transmission disequilibrium test in 943 trios multiple sclerosis families.

<p>Legend: Transmission disequilibrium test (TDT); Transmitted (T); Not transmitted (NT); p value (P); p value corrected (Pc).</p